and displays images of immunofluorescence for Pol II-Ser2-P (green) along with their corresponding nuclear staining (DAPI= blue). (C) Representative images of EU-incorporation (gray; reflecting RNA synthesis) along with their corresponding nuclear staining (DAPI= blue). (D) Quantification of total RNA and mRNA in S1 (left) and T4-2 cells (right). Total RNA was normalized to DNA (total RNA/DNA) and mRNA was normalized to total RNA/DNA (mRNA/Total RNA/DNA) (n = 6 replicates from 2 independent experiments). (E) This panel refers to Figure 1C and shows images of immunofluorescence for N-actin (green) together with their corresponding nuclear staining (DAPI= blue). (F) Pure laminin-111 (LN1), but not collagen type IV (col IV) induces depletion of N-actin. Quantification of N-actin fluorescence in S1 cells treated with col IV or pure LN1 for 24 hours (n > 250 cells/condition from 2 independent experiments). (G) Kinetics of N-actin levels in S1 cells treated with pure LN1 (n> 250 cells/condition from 2 independent experiments). (H and I) These panels refer to Figure 2A and shows immunofluorescence images for N-actin together with their corresponding nuclear staining (DAPI= blue) and quantification of N-actin fluorescence (green) (n > 250 cells/condition from 3 independent experiments). In the images of immunofluorescence showing only the green or gray channel, the nuclear are highlighted by white outlines based on DAPI staining. Data are expressed as mean ± SEM. **P < 0.01, ***P < 0.0001 and n.s. denotes no statistical significance. Scale bars in A, 50 µm, in B, C, and E, 10 µm and in H, 5 µm. Figure 3A and shows representative images of S1 cells expressing a control shRNA (ct-shRNA) or shRNA constructs against XPO6 (XPO6-shRNA-1 and XPO6-shRNA-2) stained for N-actin (green) together with their corresponding nuclear staining (blue). White outlines denote the nuclei based on DAPI staining (blue). (C) Export rate of N-actin measured with FLIP in response to XPO6 gene silencing. The statistical analysis is based on 10 cells assayed from 3 independent experiments. Data are expressed as mean ± SEM. *P< 0.05 and **P< 0.01 (D) Co-immunoprecipitation reveals the interaction of endogenous XPO6 with actin in the nuclear fraction of S1 cells after LN1 treatment (this is a reciprocal assay referring to data presented in Figure 4A ). Figure 5A and shows representative images (left) of S1 cells expressing a control shRNA (ctshRNA) or shRNA against XPO6 (XPO6-shRNA-2) stained for EdU (red) together with their corresponding nuclear staining (blue) and shows quantification (right) of EdU-positive cells. These data were derived from the same experiment shown in Figure 5A . The values for ct-shRNA (both control and LN1) are the same as presented in Figure 5A . (B) Representative images (left) of immunofluorescence for Pol II-Ser2-P (green) along with their corresponding nuclear staining (DAPI= blue) and quantification (right) for Pol II-Ser2-P fluorescence. (C) Representative images (left) of EU-incorporation assay (gray) to measure RNA synthesis along with their corresponding nuclear staining (DAPI= blue) and quantification (right) for EU fluorescence. Data are expressed as mean ± SEM. **P< 0.01 and ***P< 0.0001. Scale bars in A and C, 10 µm and in B, 5 µm. figure 5C (n > 400 structures/condition from 3 independent experiments). (B) Silencing of XPO6 in results in higher levels of N-actin in S1-3D structures. (B, left) Representative images of 3D structures stained for N-actin (green) and α6-integrin (red). In close up images, the nuclei are highlighted by white outlines. (B, right) Quantification of immunofluorescence images for N-actin (> 30 cells/condition from 3 independent experiments). (C) S1 cells, in 3D-LN1-rich gel, that have been silenced for XPO6 present disrupted apical polarity as shown by ZO-1 immunofluorescence (green), but intact basal polarity as represented by the discrete and continuous localization of α6-integrin (red) to the basal surfaces. Arrows point to ZO-1 at the apical region of the 3D structures and arrowheads indicate basal deposition of ZO-1. Data are expressed as mean ± SEM. ***P < 0.0001. Scale bars in A, 100 µm, in B, 10 µm and in C, 20 µm. Growing S1 cells expressing mYPET-tagged actin and either a shRNA control (S1-ct-shRNA) or a shRNA for XPO6 (S1-XPO6-shRNA-1) were treated with either PI3K inhibitor (LY294002) or only the vehicle (DMSO), and submitted to FLIP assay 1-2 hours after addition of the drug. Figure 7A . Phase contrast images of T4-2 cells expressing a control shRNA (ct-shRNA) or an shRNA against XPO6 (XPO6-shRNA) that have been grown in 3D-LN1-rich gel in the presence of a LY294002 or the vehicle. Data are expressed as mean ± SEM, ***P < 0.0001. Scale bar in A, 20 µm, in C, 100 µm. (E) Breast cancer patients at low risk of death express higher levels of XPO6 in comparison to patients at high risk. (E, left) Kaplan-Meier survival curves of censored Cox analysis from The Cancer Genome Atlas (TCGA)-Breast Invasive Carcinoma (n= 962 patients) database stratified by maximized XPO6 expression risk group. (E, right) Box plot showing XPO6 expression levels segregated by risk group. Red and green curves and boxes denote high-and lowrisk groups respectively. The P values of the statistics (detailed in Methods) are indicated in the plots. The analyses were carried out with the online resource SurvExpress.
Supplemental Experimental Procedures
Cell culture. The nonmalignant S1 and the malignant T4-2 of the human mammary epithelial cells, HMT-3522, were grown in a serum-free defined medium as described previously (Briand et al., 1987; Petersen et al., 1992) . For all 2D experiments, S1 cells were seeded at the density of 2 x 10 4 /cm 2 and T4-2 cells at 1 x 10 4 /cm 2 . S1 cells are smaller than T4-2 cells, therefore we routinely plate twice as much cells in comparison to T4-2 cells to yield comparable confluency and protein extracts at the end of the experiments (Lee et al., 2007;  and http://www2.lbl.gov/LBL-Programs/lifesciences/BissellLab/labprotocols/density.htm). The two cultures are similarly confluent after 4 days (~50% for S1 cells and ~60% for T4-2 cells; Figure S1 ). This is the range of confluency needed where cells are still growing but where we also have enough material for analysis. The 3D cultures (here 3D on-top assay) for S1 and T4-2 were performed as described previously (Lee et al., 2007) for a duration of 5 days. The reversion experiment with T4-2 cells was achieved with 10 μM of the PI3K inhibitor (LY294002; Life Technologies) added in the cell medium in the first day of 3D on-top assay as described previously (Liu et al., 2004) .
Antibodies. The following antibodies were used: rabbit anti-β-actin (ab1801 from Abcam; used for immunofluorescence at 1:200), goat anti-lamin B (sc-6216 from Santa Cruz; for both western blotting and immunofluorescence experiments used at 1:500), mouse anti-RNA Polymerase II-Ser2-P [MMS-129R (clone H5) from Covance; used for immunofluorescence at 1:100]; mouse anti-β-actin [A5441 (Clone AC-15) from Sigma, used for western blotting analysis]; rabbit anti-XPO6 (11408-1-AP from Proteintech; used for western blot at 1:250, for co-immunoprecipitation at 1:40, and for immunofluorescence at 1:50); rabbitanti-myc tag (ab 9106 from Abcam, used for co-immunoprecipitation at 1:200); rat anti-α6-integrin [(antiCD49f) #555734 from BD Biosciences; used for immunofluorescence at 1:500]; rabbit anti-Ki67 (VP-K451 from Vector; used for immunofluorescence at 1:500); rabbit anti-ZO1 (#7300 from Life Technologies; used for immunofluorescence at 1:100); rabbit anti-PI3K (#4392 from Cell Signaling; used for western blotting at 1:500); rabbit anti phospho-PI3K Tyr458 (p85)/Tyr 199(p55) (#4228S from Cell Signaling; used for western blotting at 1:500); rabbit anti-MAPK (#9102S from Cell Signaling; used for western blot at 1:1000); rabbit anti phospho-MAPK Thr202/Tyr204 (#4370S from Cell Signaling; used for western blotting at 1:1000); rabbit anti-AKT (#9272 from Cell Signaling; used for western blot at 1:1000); rabbit anti phospho-AKT (#9271, from Cell Signaling; used for western blotting at 1:500). Alexa fluor (Alexa 488 and Alexa 568) conjugated secondary antibodies (Life Technologies) were used at 1:400. And the HRP-conjugated secondary antibodies used for western blotting were goat anti-mouse (#31430 from Thermo Scientific; used at 1:1000); goat anti-rabbit (#32460 from Thermo Scientific; used at 1:1000); and donkey anti-goat (sc-2020 from Santa Cruz; used at 1:5000).
Plasmids, lentivirus production and infection. The gene for the monomeric fluorescent protein YPET (mYPET) was fused by PCR with the N-terminus of human β-actin using myc tag as a linker (Mori et al., 2013) . The construct DNA sequence was confirmed by sequencing. Then, the mYPET-myc-β-actin cDNA was cloned into a pLenti-EF1α-puro vector, generated in our laboratory (Mori et al., 2013) . For production of lentiviral particles, packaging plasmids and lentivirus plasmid containing mYPET-myc-β-actin or shRNA (NM_015171.2-4126s1c1 and NM_015171.1-1116s1c1 from Mission shRNA; Sigma-Aldrich) against human XPO6 were transfected into 293FT cells using FuGene6 (Roche, Basel, Switzerland) as previously described (Mori et al., 2013) . Transfected cells were cultured in DMEM containing 5% FBS, 100 U/mL penicillin and 100 μg/mL streptomycin. Culture media were replaced after 24 hours with fresh media. Forty-eight hours later, the lentivirus particles from filtered culture media (0.45 µm filters) were concentrated with Lenti-X Concentrator (#PT4421-2 from Clontech). To transduce the HMT-3522 cells, 50,000 cells were plated in each well of a 12-well plate, infected with the lentivirus with the ExpressMag beads (SHM03 from Sigma-Aldrich) according with the manufacturer's instructions. The shRNA with scrambled sequence was used as a control for gene silencing experiment. To mitigate off-target effects, the shRNA sequences used were evaluated with the bioinformatics tool siRNA Sequence Probability-of-OffTargeting Reduction (siSPOTR) (https://sispotr.icts.uiowa.edu/sispotr/tools/) (Boudreau et al., 2013) . To test whether forcing actin to accumulate in the nucleus affected non-malignant 3D phenotypes, we expressed actin containing an N-terminal nuclear localization signal (NLS) sequence, fused to enhanced Yellow Fluorescent Protein (YFP) in S1 cells. pEYFP-NLS-actin [#60613, Addgene; (Chang et al., 2011)] or only pEYFP-NLS plasmids [#56597, Addgene (Ai et al., 2008) ]. S1 cells were transiently transfected in monolayers of S1 cells with Lipofectamine 3000 reagent (#L3000001, Thermo Fisher Scientific), according to the manufacturer's instructions. To confirm the transfection, we seeded the cells on glass coverslips, fixed with 4% PFA, counterstained with DAPI, mounted with Prolong® Diamond and observed in a Leica DMi8 widefield fluorescence microscope.
ECM treatments. The treatments with different extracellular matrices were performed as published before (Spencer et al., 2011) with some modifications. In brief, S1 cells were seeded at the density of 2 x 10 4 /cm 2 and T4-2 cells at 1 x 10 4 /cm 2 in eight-well Lab-Tek II chambered slides (#15434 from Thermo Fisher Scientific), grown for 3 days and then treated for the durations indicated in the figures and figure legends with or without 5% growth factor-reduced LrECM (#354230 Matrigel® from BD Biosciences), 100 μg/mL pure LN1 (L2020 from Sigma) or 20 μg/mL type-IV collagen (#354233 from BD Biosciences). We used LrECM as a replacement for LN1 because it is less expensive than pure LN1 and it is already in gel, although pure LN1 would provide the same results. For biochemical studies, cells were grown in 75 cm 2 flasks (#353136 from BD Falcon).
Immunofluorescence. The cells were fixed with 4% of paraformaldehyde (PFA) (#15710 from Electron Microscopy Sciences) in PBS pH 7.4. Residual PFA reactivity was quenched with PBS-25 mM glycine, and cells were permeabilized with 0.5% Triton X-100 in PBS for 15 minutes. This step is critical for the detection of N-actin, since it removes most of the cytoplasmic actin that the anti-actin antibody (ab1801 from Abcam) would label otherwise (Spencer et al., 2011) allowing the nuclear signal for N-actin to stand out. The cells were then incubated in blocking buffer [1% Bovine Serum Albumin (BSA) and 5% goatserum in PBS] for 1 hour at room temperature, followed by overnight incubation with primary antibodies in blocking buffer. For co-labeling of XPO6 and lamin-B the blocking buffer contained 5% BSA-PBS. Cells were finally incubated in blocking buffer with secondary antibodies for 45 min, counterstained with 4'6-diamidino-2-phenylindole (DAPI) for 15 minutes and mounted with Prolong® Gold (P36934 from Life Technologies). For 3D-structures, the permeabilization step was extended to 16 hours and the remaining steps were done as detailed previously (Lee et al., 2007) .
5-ethynyl-2'-deoxyuridine (EdU) incorporation assay.
We used the Click-iT® EdU kit (C10337 from Life Technologies) to determine the percentage of proliferating cells cultured on 2D cells untreated or treated with LrECM. Only DNA-replicating cells incorporate EdU. After incubation with 10 µM EdU for 30 minutes, cells were fixed with PFA and subjected to EdU detection as manufacturer's instructions. The cells were then counterstained with DAPI for 15 minutes and mounted with Prolong® Gold and analyzed with a Zeiss LSM 710 confocal microscope.
5-ethynyl-uridine (EU) incorporation assay.
We used the Click-iT® RNA kit (C10330 from Life Technologies) to determine the global RNA transcription in 2D cells untreated or treated with LrECM. This assay is based on the rapid incorporation of EU into nascent RNA. After incubation with 1 mM EU for 10 minutes, cells were washed with ice-cold PBS twice, fixed with 4% PFA and subjected to EU detection as manufacturer's instructions. The cells were then counterstained with DAPI for 15 minutes and mounted with Prolong® Diamond (Life Technologies), and analyzed with Leica DMi8 widefield microscope.
Purification and quantification of nucleic acids. Nucleic acids were isolated using TRIzol reagent (#15596026, from Life Technologies) and chloroform followed by a centrifugation step to separate the solution into an aqueous phase and an organic phase. Total RNA was isolated from the aqueous phase as instructed by the manufacturer, and the genomic DNA was precipitated from the organic phase with isopropanol. Polyadenylated RNA was isolated from 20 µg of total RNA samples by using Dynabeads mRNA Purification Kit (#61021, from Life Technologies), following the manufacturer's protocol. The concentration of total RNA, mRNA and DNA was determined by measuring absorbance at 260 nm with a UV-Visible Spectrophotometer (Nanodrop 1000, Thermo Scientific). To determine the relative amount of total RNA and mRNA in cells untreated or treated with LrECM, we normalized total RNA to DNA (represented as total RNA/DNA) and mRNA to total RNA to DNA (represented as mRNA/total RNA/DNA).
Image acquisition and analysis. For quantification of N-actin, Pol II-Ser2-P and XPO6, images were taken using a laser scanning microscope (LSM)-710 from Zeiss equipped with a 63x/1.4 oil objective. Singlesection images were taken after adjusting the focus to the mid-plane (by using the DAPI channel as a reference) of most of the nuclei in a microscope field. The optical section thickness was set to 1 µm to assure minimal interference of fluorescence signals coming from the cytoplasm. The imaging settings were: zoom= 1 for N-actin and Pol II-Ser2-P and = 4 for XPO6, dimensions= 1024 x1024 pixels, image depth= 12 bit and averaging signal= 1. The fluorescence intensity of N-actin, Pol II-Ser2-P and XPO6 stainings were quantified using ImageJ (an open source software available at http://imagej.nih.gov/ij/). The DAPI channel was converted to a binary mask to delimit the nuclei and the software´s tool analyze particles was used to generate selections (outlines) of individual nuclei and the mean gray value (the sum of the gray values of all the pixels in the selection divided by the number of pixels) of N-actin and Pol II-Ser2-P staining intensities within each nuclear outline was determined. For XPO6, the immunofluorescence intensity was determined in the nuclear lamina region of individual cells. For this purpose, the enlarge tool was used to produce an outer and an inner ring by concentrically expanding or shrinking the nuclear outlines (generated as described above) by 1 µm, respectively, and then the mean gray value of XPO6 staining was determined in the area limited by the outer and inner rings. For quantification of EU incorporation, images were taken with fully motorized Leica DMi8 widefield microscope (from Leica Microsystems) equipped with a 63x/1.4 NA oil objective. Z-stacks of 40-70 optical sections (settings: optimized step size and resolution of 1392 x 1040 pixels) covering most of the nuclei in a microscope field were acquired. After 3D-blind deconvolution of the Z-stacks using the Leica Application Suite-X software (Leica Microsystems), the optical section with highest intensity of the DAPI staining was selected by using ImageJ and the mean gray value of EU staining for each individual nucleus was determined as described for N-actin and Pol II-Ser2-P quantification. To measure the size of epithelial structures resulted from 3D-LrECM cultures, phase contrast micrographies were taken on day 5 of culture using a 4x objective of a Zeiss Axio Vert microscope with a digital camera attached. The images were binarized and the projected area (size) of individual structures automatically outlined and measured using the analyze particles tool of ImageJ. For quantification of YFP fluorescence intensity and size in 3D structures formed by S1 cells transfected with a YFP-NLS-actin or YFP-NLS construct, YFP fluorescence and contrast phase images were taken with a Leica DMi8 widefield microscope with a 40x/0.60 NA objective. After manually drawing the outlines of the structures, the projected area and mean gray value of YFP within the structure outlines were determined using the analyze particles tool of ImageJ. Pearson´s correlation was conducted with GraphPad Prism 7.0 software (GraphPad Software Inc.). To quantify EdU and KI67 staining, the number of total and stained cells was obtained by using the cell counter application in ImageJ and the percentages of EdU-or Ki67-positive cells were determined. All imaging acquisition parameters were kept constant for each experiment. The number of cells and structures analyzed for each condition is indicated in the figure legends.
Photobleaching experiments. The S1 cells expressing mYPET-tagged actin were seeded on 8-well Lab Tek II chambered #1.5 coverslips (#155409 from Thermo Scientific Nunc) at density and culture conditions described above and indicated in the figure legends. Fluorescence loss in photobleaching (FLIP) and fluorescence recovery in photobleaching (FRAP) experiments were performed as previously described (Dopie et al., 2012; Ho et al., 2013; Skarp and Vartiainen, 2013) , with some modifications. For both experiments, we used a 63x/1.4 NA oil objective of the inverted Zeiss LSM 710 confocal microscope (Carl Zeiss) equipped with a system of control of temperature and CO2 concentration respectively set for 37 o C and 5%. The image acquisition settings were; zoom= 4, dimensions= 256 x 256 pixels, image depth= 12-bit, pixel dwell= 1.27 µs, average= 1 and optical section thickness= 2 µm. For FRAP studies, the cells were scanned two times before photobleaching a cell nucleus with 20 bleach iterations at 100% intensity of a 514-nm laser line. Images were then continually collected with laser power attenuated to 7%. For analysis, only the first 15 seconds of fluorescence recovery were used. We set the prebleach nuclear fluorescence intensity to one and the lowest nuclear fluorescence intensity (from the first image captured after the bleach pulses) to zero. The nuclear fluorescence variation was plotted as a function of time and the 'one phase association equation' (Y=(Y0 -Plateau)*exp(-K*X)) + Plateau) contained in the software Graph Pad Prism was used to calculate the import rate (K in the equation) of N-actin. For FLIP experiments, two single scans were acquired, followed by repeated photobleaching using 20 bleach pulses at 100% intensity of a 514-nm laser line of the entire cytoplasm at intervals for 400 cycles. After each cycle of photobleaching, three single-section images were then collected with the laser power reduced to 7%. For analysis, the background was subtracted and nuclear fluorescence intensity before bleaching was set to one. The nuclear fluorescence variation was plotted as a function of time and the 'one phase decay equation' (Y= (Y0 -Plateau)* exp(-K*X) + Plateau) from the software Graph Pad Prism was used to obtain the export rate (K in the equation) of N-actin. For chemical inhibition of PI3K and MAPK pathways, S1 cells were seeded into wells on an eight-chamber #1.5 coverslip and treated with 40 μM PD98059 (MEK inhibitor), 10 μM LY294002 (PI3K inhibitor) or DMSO (used as a vehicle control). The cells were submitted to FLIP 1-2 hours after beginning the treatment.
Preparation of cytoplasmic and nuclear extracts and total cell lysates. To generate cytoplasmic and nuclear-enriched extracts, cells were washed two times with ice cold PBS pH 7.4, and harvested by scraping in buffer A (10 mM HEPES pH 7.5, 10 mM KCl, 0.1 mM EDTA, 1 mM dithiothreitol, 0.5% NP-40) containing protease (#04693116001 from Roche) and phosphatase inhibitors (#P5726 from SigmaAldrich), incubated on ice for 20 min with intermittent mixing. Tubes were vortexed to disrupt cell membranes and then centrifuged at 12,000 x g at 4°C for 10 min. The supernatant was stored at -80°C until further use as cytoplasmic extract. The pelleted nuclei were washed three times with buffer A to remove residual cytoplasmic contamination, then resuspended in buffer B (8 M Urea, 400 mM NaCl, 0.5% NP40, 50 mM Na2PO4, 50 mM TRIS pH 8.0). After 30 minutes of incubation in ice, the samples were sonicated three times for 10 seconds at minimum power and, finally centrifuged for 15 minutes at 15,000 x g at 4 o C, supernatant was collected and stored at -80°C until further use as nuclear extract. Protein concentration was determined using the DC Protein Assay kit (#500-0116 from BioRad). For total cell lysate protein extraction, samples were lysed using modified RIPA buffer (50 mM HEPES pH 7.4, 150 mM NaCl, 10% glycerol, 1% Triton X-100, 10 mM sodium pyrophosphate containing 1.5 mM MgCl2, 1 mM EGTA, 1% sodium deoxycholate, 0.25 mM Na3VO4, 100 mM NaF and the proteinase inhibitor cocktail). Protein concentration was determined using the DC Protein Assay kit (#5000112 from BioRad). Fifteen-micrograms, 10 µg and 5 µg of total cell lysate, cytoplasmic and nuclear fractions, respectively, were mixed with 2x Laemmeli sample buffer (4% SDS, 20% glycerol, 120 mM Tris pH 6.8, 0.02% bromophenol blue and 0,2% 2-mercaptoethanol) heated at 95°C for 5 minutes, and submitted to western blotting.
Co-Immunoprecipitation. Cells were harvested by scraping in ice cold PBS pH 7.4, pelleted at 1,000 x g and then resuspended in a hypotonic buffer [20 mM HEPES pH 7.4, 1 mM DDT, 10 µM Na2MoO4, 0.25 mM Na3VO4, 100 mM NaF and protease inhibitor cocktail (#539131 from EMD Millipore)]. After incubation on ice for 15 minutes and addition of 0.5% Triton X-100, the samples were centrifuged for 15 minutes at 15,000 g at 4 o C. The nuclear pellets were then washed three times with the hypotonic buffer to remove any residual cytosolic contaminations and resuspended in a nuclear lysis buffer (20 mM HEPES pH 7.4, 10% glycerol, 200 mM NaCl, 1.5 mM MgCl2, 0.1% Triton X-100, 10 µM Na2MoO4, 0.25 mM Na3VO4, 100 mM NaF and proteinase inhibitor cocktail). Nuclear extracts containing 200 µg of protein were incubated with control IgG or primary antibodies as described above. Precipitation was performed with protein-G magnetic beads (S1430S from New England Biolabs) according to the manufacturer's instructions. Ten percent of total precipitates were mixed with Laemmeli sample buffer heated at 95°C for 5 minutes, and submitted to western blotting. Western blotting. Protein samples were loaded into a pre-cast 4-20% tris-glycine polyacrylamide gel using the NOVEX system (Life Technologies). Resolved proteins were transferred to nitrocellulose membrane (Whatman) followed by blocking in TBS, 0.5% Tween-20 with 5% BSA. Membranes were incubated in TBS, 0.5% Tween-20 with 5% BSA containing primary antibodies. Primary antibodies were detected with HRP conjugated anti-IgG and the bands were detected using enhanced chemiluminescent system (SuperSignal detection kit, from Thermo). Chemiluminescence signal was captured with a FluorChem 8900 analysis system (Alpha Innotech), and each band integrated optical density was determined using the gel analyzer application in Image J and then normalized to the loading control or the total protein before determining fold-change or kinase activation ratio, respectively.
Kaplan-Meier survival analysis.
To compare the survival profiles with respect to the expression of XPO6 of breast cancer patients, we used the online resource SurvExpress (Aguirre-Gamboa et al., 2013) . The database used was generated by The Cancer Genoma Atlas (TCGA; Breast Invasive Carcinoma). The patients (n = 962) were stratified based on high and low XPO6 expression with risk groups maximized and censored for survival in days. The partitioning of risk groups was optimized using the maximize risk group tool in SurvExpress. The Kaplan-Meier curves were compared with the Log-Rank test (Cox analysis) and the statistical difference between low risk and high risk groups was assessed with t-test. Details of the SurvExpress analysis are described at http://bioinformatica.mty.itesm.mx/sites/default/files/SurvExpress%20Tutorial%20final-4.pdf.
Statistical analysis. Statistical analysis was performed using GraphPad Prism 7.0. Data are presented as mean ± s.e.m. The number of samples analyzed and the number of times that the experiments were performed are indicated in the respective figure legends. Two-tailed unpaired t-test was used for statistical comparisons of two conditions. For statistical comparisons of three or more conditions, ANOVA followed by Dunnett test was used. Statistical significance was defined as P < 0.05.
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